Treatment for Pediatric Obesity

Phase-Based Progress Estimates
The University of Texas Health Science Center at Houston, Houston, TX
Pediatric Obesity+2 More
Healthy Lifestyle Behavioral Intervention (MBS -supported intervention) - Behavioral
< 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to Conduct a proof of concept study to assess feasibility, acceptability, and effectiveness of an Metabolic and bariatric surgery (MBS) -supported healthy lifestyle behavioral intervention among adolescent patients, their families, and their clinical team.

Eligible Conditions

  • Pediatric Obesity
  • Bariatric Surgery Candidates
  • Obesity, Adolescent

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

7 Primary · 0 Secondary · Reporting Duration: pre surgery, 3 months post surgery, 6 months post surgery

Month 6
Change in Health-related quality of life as measured by the HRQOL-14
Month 6
Change in Blood Insulin Levels
Change in Blood Lipid Levels as Assessed by Lipid Panel
Month 6
Change in Blood Glucose Level
Change in Diastolic Blood Pressure
Change in HbA1c levels
Change in Systolic Blood Pressure

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Experimental Group · 1 Intervention: Healthy Lifestyle Behavioral Intervention (MBS -supported intervention) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: pre surgery, 3 months post surgery, 6 months post surgery

Trial Background

Prof. Sarah E Messiah, Professor
Principal Investigator
The University of Texas Health Science Center, Houston
Closest Location: The University of Texas Health Science Center at Houston · Houston, TX
Photo of Houston  1Photo of Houston  2Photo of Houston  3
2008First Recorded Clinical Trial
1 TrialsResearching Pediatric Obesity
190 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.